Friday November 27 2009 | Biotechnology feed | All feeds

«CXCR4

Below is an extended CXCR4 patents listing. Click here to return to the gene page.

Patents :
US Patent No.	Title
7569579	Cyclopropyl compounds as ccr5 antagonists
7585861	HIV inhibiting 1,2,4-triazines
7585867	Substituted thiazolo[4,5-d]pyrimidin-2(3H)-one
7585968	Compositions and their uses directed to thymus and activation-regulated chemokine (TARC)
7588767	Microorganisms for therapy
7588771	Microorganisms for therapy
7589080	.beta.-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
7589167	ZA loops of bromodomains
7589182	Anti-sulfotyrosine antibodies
7589197	Pyrimidine compounds
7589204	Indane compounds as CCR5 antagonists
7585675	Inhibition of HIV and SHIV replication with antisense interleukin-4
7585507	Nucleic acid molecules and polypeptides for immune modulation
7583379	Surface enhanced raman spectroscopy (SERS) systems and methods of use thereof
7569723	Benzoic acid derivatives as non nucleoside reverse-transcriptase inhibitors
7572640	Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
7572810	Alkene piperidine derivatives as antiviral agents
7572813	Cyclic derivatives as modulators of chemokine receptor activity
7575750	Human immunodeficiency virus (HIV) gp41 peptide derivatives with enhanced solubility and antiviral activity
7576097	Tropane derivatives useful in therapy
7579007	Production of "biological carriers" for induction of immune responses and inhibition of viral replication
7579324	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
7579342	Pteridine compounds for the treatment of psoriasis
7582644	Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
7589207	Cyclohexyl compounds as CCR5 antagonists
7592008	Membrane scaffold proteins
7601844	Piperidinyl derivatives as modulators of chemokine receptor activity
7604939	Methods of identifying active BRM expression-promoting HDAC inhibitors
7608256	Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
7608273	Recombinant lentivirus encoding modified GP 120 signal sequences
7608590	HCV NS-3 serine protease inhibitors
7608688	HIV-1 protein associated with broadly reactive neutralizing antibody response
7608699	Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof
7608726	Substituted indolepyridinium as anti-infective compounds
7611712	Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
7611839	Methods for diagnosing RCC and other solid tumors
7601341	Vascular endothelial growth factor fusion constructs used to inhibit osteoclastogenesis
7598231	Tricyclic compound, compositions, and methods
7598072	Assay to detect viral uncoating
7592010	Albumin fusion proteins
7592014	Stabilized viral envelope proteins and uses thereof
7592324	RNAi-mediated inhibition of ocular targets
7592326	Method for stimulating the immune, inflammatory or neuroprotective response
7595049	IGG1 monoclonal antibody with anti-HIV neutralizing activity
7595159	Prediction of Parkinson's disease using gene expression levels of peripheral blood samples
7595298	Polypeptides having anti-HIV activity and compositions comprising same
7598028	Compositions and methods for detecting and treating prostate disorders
7598031	Method for the detection of gene transcripts in blood and uses thereof
7598043	Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics
7612181	Dual variable domain immunoglobulin and uses thereof

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

«CXCR4

Below is an extended CXCR4 patents listing. Click here to return to the gene page.

Patents :